KemPharm (KMPH) Updates on IP Initiatives; Recently Granted U.S. Patent
Tweet Send to a Friend
KemPharm (NASDAQ: KMPH) announced several enhancements to KemPharm's U.S. and global intellectual property estate governing its portfolio of prodrug product ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE